News
Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...
Positron Emission Tomography Market to grow at 5% CAGR driven by oncology and neurology uses by 2030
The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...
A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.
Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...
Positron Emission Tomography (PET) and Computed Tomography (CT) are complementary imaging modalities that have revolutionised diagnostic and research strategies in modern medicine.
Mayo Clinic Jacksonville supports a blood test for to diagnose Alzheimer's while Baptist Health implanted its first atrial ...
Correspondence Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography Published November 23, 2000 N Engl J Med 2000;343: 1571 - 1573 DOI: 10.1056/NEJM200011233432113 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback